AbbVie
ABBV
ABBV
2,591 hedge funds and large institutions have $129B invested in AbbVie in 2020 Q4 according to their latest regulatory filings, with 355 funds opening new positions, 1,104 increasing their positions, 872 reducing their positions, and 90 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 2,361 → 2,591 (+230)
0.8% less ownership
Funds ownership: 68.7% → 67.9% (-0.8%)
17% less call options, than puts
Call options by funds: $2.12B | Put options by funds: $2.57B
Holders
2,591
Holding in Top 10
161
Calls
$2.12B
Puts
$2.57B
Top Buyers
| 1 | +$410M | |
| 2 | +$309M | |
| 3 | +$264M | |
| 4 |
Morgan Stanley
New York
|
+$250M |
| 5 |
BlackRock
New York
|
+$231M |
Top Sellers
| 1 | -$712M | |
| 2 | -$340M | |
| 3 | -$337M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$298M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$277M |